Filter Results:
(694)
Show Results For
- All HBS Web
(1,022)
- News (154)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (441)
Show Results For
- All HBS Web
(1,022)
- News (154)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (441)
Sort by
- March 2011 (Revised March 2014)
- Teaching Note
Intellectual Ventures
By: Andrei Hagiu
Teaching Note for 710423. View Details
- May 1995
- Teaching Note
C.K. Coolidge, Inc. (A) TN
By: David E. Bell
Teaching Note for (9-894-017). View Details
- 07 Jun 2020
- Working Paper Summaries
Financial Distancing: How Venture Capital Follows the Economy Down and Curtails Innovation
- 22 Jan 2013
- First Look
First Look: Jan. 22
performance-survival, employment, and growth-and firm innovative performance-quantity, quality, and nature of patents and papers-by comparing funded and unfunded firms. To address endogeneity around selection bias, we use a qualitatively... View Details
Keywords: Sean Silverthorne
- 08 Mar 2012
- Research & Ideas
Unplugged: What Happened to the Smart Grid?
"You can be unique, the only company that has this product or service. You have a patent for Lipitor, and you get to make a lot of money," she explained. "Or you have tightly held complementary assets. Look at Coca-Cola.... View Details
- 05 Dec 2017
- First Look
First Look at New Research and Ideas, December 5, 2017
https://www.hbs.edu/faculty/Pages/item.aspx?num=53563 The Use and Misuse of Patent Data: Issues for Corporate Finance and Beyond By: Lerner, Josh, and Amit Seru Abstract—Patents and citations are powerful tools for understanding innovative... View Details
Keywords: Sean Silverthorne
- July 1999
- Case
Quickturn Design Systems, Inc. (E)
By: Jay W. Lorsch and Katharina Pick
Supplements the (A) case. View Details
Keywords: Patents; Governing and Advisory Boards; Behavior; Lawsuits and Litigation; Organizations; Acquisition; Corporate Governance; Service Industry
Lorsch, Jay W., and Katharina Pick. "Quickturn Design Systems, Inc. (E)." Harvard Business School Case 400-006, July 1999.
- 16 Jan 2018
- First Look
First Look at New Research and Ideas, January 16, 2018
on average, more valuable—they are more clinically effective; have higher patent citations; lead to more revenue and to higher stock market value. Using variation in the expansion of Medicare prescription drug coverage, we show that firms... View Details
Keywords: Sean Silverthorne
- November 1995 (Revised February 1996)
- Case
Monsanto Company: The Coming of Age of Bio-Technology
By: Ray A. Goldberg and Thomas N. Urban Jr
Monsanto has one product, Roundup, accounting for 30% of company net income and is going off patent. How should the company position itself and its products in the future? View Details
Goldberg, Ray A., and Thomas N. Urban Jr. "Monsanto Company: The Coming of Age of Bio-Technology." Harvard Business School Case 596-034, November 1995. (Revised February 1996.)
- November 1978 (Revised October 1989)
- Case
Amicon Corp. (B)
Details the negotiation between Amicon and three potential licensees, Jackson, Maynard-Smith and Behrstein. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Capon, Noel. "Amicon Corp. (B)." Harvard Business School Case 579-094, November 1978. (Revised October 1989.)
- 08 Nov 2016
- First Look
November 8, 2016
work in linked fields. Our analysis uses 1.8 million U.S. patents and their citation properties to map the innovation network and its strength. Past innovation network structures are calculated using citation patterns across technology... View Details
Keywords: Sean Silverthorne
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
sector. Pisano proposes more vertical integration, fewer but closer long-term collaborations, and quasi-public corporations. In academia he calls for more cross-disciplinary research and for universities to strive to disseminate new knowledge and liberate it from... View Details
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- 16 Jul 2024
- Research & Ideas
Weighing Digital Tradeoffs in Private Equity
and sales by 7 percent. Moreover, the team found that improving digital technology increased innovation; companies that received more technology investment held more new patents afterward. “If there are firms that haven’t been interested... View Details
- June 2019
- Teaching Note
Zebra Medical Vision
By: Shane Greenstein and Sarah Gulick
Teaching note is meant to accompany Zebra Medical Vision case, which offers a look at a company’s decisions as a small startup competing with other startups and major technology companies. It also demonstrates the challenges faced by a machine learning company working... View Details
- September 2007 (Revised May 2011)
- Case
Commercializing an MRI Breakthrough
The challenges and best strategies for the commercialization of university technologies are illustrated in this case which documents an MRI breakthrough that arose from the Charles Marcus laboratory at Harvard. Students discuss the interdependencies of intellectual... View Details
Keywords: Business Model; Decision Choices and Conditions; Higher Education; Patents; Research and Development; Science-Based Business; Commercialization
Fleming, Lee. "Commercializing an MRI Breakthrough." Harvard Business School Case 608-064, September 2007. (Revised May 2011.)
- September 2010
- Teaching Note
Alnylam Pharmaceuticals: Building Value from the IP Estate (TN)
By: Willy C. Shih
Teaching Note for 611009. View Details
- March 2017 (Revised February 2025)
- Case
Edwin Land: The Art and Science of Innovation
By: Tom Nicholas, Christopher T. Stanton and Matthew G. Preble
Throughout the second half of the 20th century, Polaroid first invented—and then continuously reinvented—the field of instant photography. Under the leadership of its mercurial founder Edwin Land, the company regularly released new instant cameras and films, often... View Details
Keywords: Instant Photography; Company History; Change Management; Disruption; Forecasting and Prediction; Entrepreneurship; Business History; Innovation Strategy; Disruptive Innovation; Innovation and Management; Intellectual Property; Patents; Product Marketing; Brands and Branding; Product Launch; Product Development; Chemical Industry; Consumer Products Industry; United States
Nicholas, Tom, Christopher T. Stanton, and Matthew G. Preble. "Edwin Land: The Art and Science of Innovation." Harvard Business School Case 817-107, March 2017. (Revised February 2025.)
- 21 Nov 2005
- Research & Ideas
Making Credibility Your Strongest Asset
this without a patent or a copyright. In theory, anyone could try to horn in on his territory. Surely some are trying; there are no formal barriers to entry. Rovell's competitive advantage is his reputation. Foster A Reputation For... View Details
Keywords: by Michael Wheeler
- June 2011
- Teaching Note
Zespri (TN)
By: Jose B. Alvarez and Mary Shelman
Teaching Note for 511001. View Details